Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in India

CompletedOBSERVATIONAL
Enrollment

532

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

November 30, 2017

Study Completion Date

April 23, 2018

Conditions
Hepatitis C Virus
Interventions
DRUG

SOF

SOF tablets administered orally once daily based on approved prescribing information

Trial Locations (26)

110029

A.I.I.M.S., New Delhi

110060

Sir Ganga Ram Hospital, New Delhi

122001

Artemis Hospital, Gurgaon

144001

Dayanand Medical College & Hospital, Ludhiana

160012

Postgraduate Institute of Medical Education and Research, Chandigarh

221007

Om Research Center, Om Surgical Center & Maternity Home, Varanasi

226003

KGMU Medical College, Lucknow

M.V. Hospital and Research Centre, Lucknow

226010

K. R. M. Hospital & Research Centre, Lucknow

302001

S.R. Kalla Memorial Gastro & General Hospital, Jaipur

302004

SMS Medical College & Hospital, Jaipur

302012

Marudhar Hospital, Jaipur

380015

Sanjivani Superspeciality Hospital Clinical Research Department, Ahmedabad

Saviour Hospital, Ahmedabad

395002

Nirmal Hospital Pvt. Ltd., Surat

400008

BYL Nair Hospital & T N Medical College, Mumbai

500035

Aware Global Hospital, Hyderabad

560017

Manipal Hospital, Bengaluru

560098

BGS global Hospitals, Bengaluru

600100

Global Hospitals & Health City, Chennai

600116

Sri Ramachandra Medical College and Research, Chennai

682040

Lakeshore Hospital, Kochi

500 004

Global Hospitals, Hyderabad

440 010

Midas Institute of Gastro-enterology, Nagpur

641 005

VGM Hospital, Coimbatore

700 020

Institute of Post Graduate Medical Education And Research, Kolkata

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gilead Sciences

INDUSTRY